Periprocedural to 1-year safety and efficacy outcomes with the Pipeline Embolization Device with Shield technology for intracranial aneurysms: a prospective, post-market, multi-center study

BACKGROUND: The first and second generations of the Pipeline Embolization Device (PED) have been widely adopted for the treatment of intracranial aneurysms (IAs) due to their high associated occlusion rates and low morbidity and mortality. The objective of this study was to evaluate the safety and e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurointerv Surg
Autors principals: Rice, Hal, Martínez Galdámez, Mario, Holtmannspötter, Markus, Spelle, Laurent, Lagios, Konstantinos, Ruggiero, Maria, Vega, Pedro, Sonwalkar, Hemant, Chapot, René, Lamin, Saleh
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Hemorrhagic Stroke
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569365/
https://ncbi.nlm.nih.gov/pubmed/32482834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2020-015943
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars